Revolutionizing medicinal chemistry: the application of artificial intelligence (AI) in early drug discovery

R Han, H Yoon, G Kim, H Lee, Y Lee - Pharmaceuticals, 2023 - mdpi.com
Artificial intelligence (AI) has permeated various sectors, including the pharmaceutical
industry and research, where it has been utilized to efficiently identify new chemical entities …

Artificial intelligence in drug metabolism and excretion prediction: recent advances, challenges, and future perspectives

TTV Tran, H Tayara, KT Chong - Pharmaceutics, 2023 - mdpi.com
Drug metabolism and excretion play crucial roles in determining the efficacy and safety of
drug candidates, and predicting these processes is an essential part of drug discovery and …

Trends and patterns in cancer nanotechnology research: A survey of NCI's caNanoLab and nanotechnology characterization laboratory

W Ke, RM Crist, JD Clogston, ST Stern… - Advanced drug delivery …, 2022 - Elsevier
Cancer nanotechnologies possess immense potential as therapeutic and diagnostic
treatment modalities and have undergone significant and rapid advancement in recent …

Artificial intelligence and machine learning for lead-to-candidate decision-making and beyond

D McNair - Annual review of pharmacology and toxicology, 2023 - annualreviews.org
The use of artificial intelligence (AI) and machine learning (ML) in pharmaceutical research
and development has to date focused on research: target identification; docking-, fragment …

Prioritizing safeguarding over autonomy: Risks of llm agents for science

X Tang, Q Jin, K Zhu, T Yuan, Y Zhang, W Zhou… - arXiv preprint arXiv …, 2024 - arxiv.org
Intelligent agents powered by large language models (LLMs) have demonstrated substantial
promise in autonomously conducting experiments and facilitating scientific discoveries …

[HTML][HTML] Machine learning and artificial intelligence in therapeutics and drug development life cycle

S Borkotoky, A Joshi, V Kaushik… - Drug Development Life …, 2022 - intechopen.com
In recent years, the pharmaceutical business has seen a considerable increase in data
digitization. With digitization, however, comes the challenge of obtaining, analyzing, and …

Machine learning and artificial intelligence: a paradigm shift in big data-driven drug design and discovery

P Pasrija, P Jha, P Upadhyaya, M Khan… - Current Topics in …, 2022 - ingentaconnect.com
Background: The lengthy and expensive process of developing a novel medicine often takes
many years and entails a significant financial burden due to its poor success rate …

From understanding diseases to drug design: can artificial intelligence bridge the gap?

AC Pushkaran, AA Arabi - Artificial Intelligence Review, 2024 - Springer
Artificial intelligence (AI) has emerged as a transformative technology with significant
potential to revolutionize disease understanding and drug design in healthcare. AI serves as …

New drug design avenues targeting Alzheimer's disease by pharmacoinformatics-aided tools

L Arrué, A Cigna-Méndez, T Barbosa… - Pharmaceutics, 2022 - mdpi.com
Neurodegenerative diseases (NDD) have been of great interest to scientists for a long time
due to their multifactorial character. Among these pathologies, Alzheimer's disease (AD) is of …

Quantum and Classical Evaluations of Carboxylic Acid Bioisosteres: From Capped Moieties to a Drug Molecule

AMA Osman, AA Arabi - ACS omega, 2022 - ACS Publications
Using the Quantum Theory of Atoms in Molecules, the average electron density (AED) tool
was developed and employed to quantitatively evaluate the similarities between bioisosteric …